Skip to content

Treadmill walking in subjects with Parkinson's disease

Effects of treadmill walking training with additional body load in subjects with Parkinson's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5qffrt
Enrollment
Unknown
Registered
2012-02-02
Start date
2011-01-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological gait disorders, Parkinson's disease

Interventions

The training protocol will occurr over 4 consecutive weeks, with three weekly sessions of 30 minutes each. Participants allocated to one of three groups (experimental I, II experimental and control) w
other
E01.370.600.250

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Idiopathic Parkinson's disease, diagnosed by a neurologist experienced in movement disorders, according to the criteria of brain bank in London; Both sexes aged over 40 and less than 75 years; In the moderate stage of disease (stages 2 and 3, according to the disability scale of Hoehn and Yahr modified) Use of antiparkinsonian medication; Walk without any brace or assistive device to walk independently, a walkway of 8 meters (m); Absence of other neurological disorders, musculoskeletal, cardiovascular and / or breathing that prevent treadmill gait training; No visual changes and / or uncorrected hearing, that might interfere with the implementation of the Protocol; Absence of severe cognitive impairment that prevented understanding of simple verbal instructions, as detected by the mini mental state examination; Not having been subjected to surgery extereotáxica; Signing the consent form (ICF).

Exclusion criteria

Exclusion criteria: Blood pressure (SBP) and systolic and diastolic values above, respectively, 200 mmHg and 110 mmHg before and / or after training; Heart rate (HR) above the permitted submaximal values, calculated by formula [FCsub = 0.75 x (220 - age)]; Change in dose and / or the type of antiparkinsonian medication during the training period; Presence of pain and / or severe muscle fatigue that prohibits continued the exercise.

Design outcomes

Primary

MeasureTime frame
Expected Outcome: Increased speed, stride length, step cadence and percentage of time balance and reduction in the percentage of support time and double support, the group submitted to training with the addition of 10% load. For these outcomes will be analyzed: spatial and temporal variables - speed (m / s), stride length (m), stride length (m), cadence (steps / min), percentage of the time balance (%), percent support time (%) and percentage of double support time (%). Expected outcome: Increase in measurements of angular variables. For this outcome will be analyzed: angular variables - the hip, the maximum extension in support maximum bending in the balance and range of motion (ROM) of the hip, knee, supporting the maximum extent, the maximum flexion in swing, the angle knee ROM at initial contact and knee and ankle, the maximum dorsiflexion in swing, plantar flexion of the fingers when collecting soil at the end of the stance phase (toe-off), the ankle angle at initial contact and ADM ankle.

Secondary

MeasureTime frame
- Expected outcome: reduction in the values of the activity domain of daily living and motor examination. For this outcome will be analyzed to assess the scale unified Parkinson's disease (UPDRS) before and after training, which assesses the severity of Parkinson's disease, so clinical and functional. Scores range from 0 to 4, where higher scores are related to a greater degree of severity of PD.

Countries

Brazil

Contacts

Public ContactLarissa Trigueiro

Universidade Federal do Rio Grande do Norte

larissacoutinho@gmail.com55 81 9668-1554

Outcome results

None listed

Source: REBEC (via WHO ICTRP)